Skip to main navigation

Gamida - Top Nav

Contact
Careers

Main Nav

Who We Are
Our R&D
Patients & Families
Healthcare Professionals
Investors & Media
Careers
Contact

Main Nav

Who We Are
Our R&D
Patients & Families
Healthcare Professionals
Investors & Media
Careers
Contact

In the News

In the News

What Trends Are 9 Biopharma CEOs Paying Attention To?

December 1, 2021

Source

Life Science Leader

Reflection And Projection 2.0 – 15 CEOs Map Biopharma’s Present And Future

December 1, 2021

Source

Life Science Leader

Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study

October 21, 2021

Source

Blood

Omidubicel Improves Outcomes, Reduces Hospital Stay for Patients with Hematologic Malignancies

July 20, 2021

Source

ASH Clinical News

10 Gene and Cell Therapy Companies to Watch

July 16, 2021

Source

GeneTherapyLive

Meeting The Need For High-Quality Cells In Therapeutic Applications

June 23, 2021

Source

Cell & Gene

Improving Bone Marrow Transplant With Omidubicel

June 22, 2021

Source

GeneTherapyLive

Phase 3 Study Shows Omidubicel Is Effective, Safe in Treatment of Patients With Hematologic Malignancies in Need of Bone Marrow Transplant

March 26, 2021

Source

Pharmacy Times

Shareholder Tools

Print Page

Email Alerts

RSS

Contacts

Search

© Gamida Cell

Gamida - Footer Info Nav

Privacy Policy
Terms of Use
Sitemap